Skip to main content
. 2019 Aug 23;9:12308. doi: 10.1038/s41598-019-48711-2

Figure 5.

Figure 5

Sequential addition of fresh CTL cohorts results in better control of tumor growth in vivo. C57BL/6 mice were injected subcutaneously with 2 × 106 OVA+ B16 tumor cells. On day 5, mice were adoptively transferred with 6 × 106 activated OT-I CD8+ T cells either in 1 injection or in 3 injections of 2 × 106 each with a time interval of 4 hours. A third group served as control with no CTL injection. Tumor growth was monitored over time. Data are from three independent experiments performed on 3 mice per group and are represented as mean +/− SD. Data was analyzed by two-way repeated measures ANOVA using the GraphPad Prism software. ***P < 0.0001.